myeloproliferative disorders
Showing 26 - 50 of 59
Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Myelocytic Leukemia Trial run by the NHLBI (Isolex 300i Stem Cell
Completed
- Acute Lymphocytic Leukemia
- +4 more
- Isolex 300i Stem Cell Selection
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2018
Acute Leukemia, MDS, Myeloproliferative Disorders Trial in Marseille (Blood sampling, Bone marrow aspirate, Skin biopsy)
Recruiting
- Acute Leukemia
- +2 more
- Blood sampling
- +3 more
-
Marseille, FranceInstitut Paoli-Calmettes
Jul 24, 2018
Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine
Unknown status
- Myeloproliferative Disorders
-
Nice, FranceCHU de Nice
Jul 23, 2018
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,
Terminated
- Myelodysplastic Syndrome
- +9 more
-
Phoenix, Arizona
- +6 more
Feb 13, 2018
Myeloproliferative Disorders, Leukemia, Lymphoma Trial (umbilical cord blood transplantation)
Terminated
- Myeloproliferative Disorders
- +3 more
- umbilical cord blood transplantation
- (no location specified)
Dec 3, 2017
Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Minneapolis (Leuprolide, hematopoietic cell transplant, reduced
Terminated
- Multiple Myeloma
- +4 more
- Leuprolide
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
MDS, Myeloproliferative Disorders, Leukemia, Lymphocytic Trial in Tampa (Busulfan, Fludarabine)
Completed
- Myelodysplastic Syndromes
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 20, 2017
Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Houston (drug, radiation, biological, procedure)
Terminated
- Leukemia
- +3 more
- ARA C
- +5 more
-
Houston, TexasTexas Children's Hospital
Mar 24, 2016
Patients With Myeloproliferative Disorders
Withdrawn
- Myeloproliferative Disorders
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital, Shandong University
Apr 18, 2016
Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Chronic Myelogenous Leukemia (CML) Trial
Completed
- Acute Myeloid Leukemia in Remission
- +7 more
- POL6326
- +2 more
-
Kansas City, Kansas
- +1 more
Feb 25, 2016
B-Receptor Signaling in Cardiomyopathy
Completed
- Carcinomas
- +37 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2015
Patients With Chronic Myeloproliferative Diseases
Completed
- Myeloproliferative Disorders
- Pulmonary Hypertension
- Echocardiography, spiroergometry, cardiac catheterization
-
Graz, AustriaMedical University of Graz, Pulmonology
Sep 7, 2015
Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as
Completed
- Myeloproliferative Disorders
- +2 more
- Total Lymphoid Irradiation (TLI)
- Anti-Thymocyte Globulin as Conditioning (ATG)
-
Stanford, CaliforniaStanford University School of Medicine
Mar 16, 2015
AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))
Completed
- AML
- +3 more
- STA-9090 (ganetespib)
-
Boston, Massachusetts
- +2 more
Sep 17, 2014
Investigation of the Cylex® ImmuKnow® Assay
Completed
- Leukemia
- +8 more
-
Indianapolis, IndianaIndiana Universtiy Simon Cancer Center
Sep 10, 2014
Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)
Terminated
- Preleukemia
- +4 more
- Fludarabine
- +2 more
-
Chicago, IllinoisThe Uniiversity of Chicago
Mar 14, 2014
Myeloproliferative Disorders Trial in Houston (SB939)
Completed
- Myeloproliferative Disorders
-
Houston, TexasUT MD Anderson Cancer Center
Dec 13, 2013
Unrelated Stem Cell Transplantation for Hematopoietic Disorders
Completed
- CML
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 1, 2013
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Apr 1, 2013
Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)
Withdrawn
- Myeloproliferative Disorders
- +7 more
- aprepitant
- ondansetron hydrochloride
- (no location specified)
Mar 29, 2013